SCHEMBL20580855

SCHEMBL20580855

Cn1cc(NC(=O)O)cc1C(=O)Nc1ccc2oc(C(=O)N3CCCCC3)cc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 7/20 0.50
▸ NPC1 O15118 6/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ MAPT P10636 3/20 0.50
▸ LMNA P02545 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ HPGD P15428 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ HRAS P01112 4/20 0.46
▸ ESR1 P03372 4/20 0.46
▸ ESR2 Q92731 4/20 0.46
▸ HRH4 Q9H3N8 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ PKM P14618 1/20 0.42
▸ SYK P43405 1/20 0.42
▸ AR P10275 2/20 0.42
▸ GRIN2B Q13224 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20580879 0.91 RAB9A (0.51) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL20581440 0.91 HRH4 (0.44) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL18976462 0.87 NPC1 (0.45) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL20581209 0.82 HRAS (0.49) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL20581193 0.81 AR (0.61) RAB9ANPC1LMNASMN1; SMN2HPGD
SCHEMBL20581348 0.80 HRAS (0.49) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL20581392 0.80 AR (0.62) LMNASMN1; SMN2POLBAR
SCHEMBL18976206 0.79 RAB9A (0.46) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL20580684 0.79 ALDH1A1 (0.47) RAB9AALDH1A1LMNASMN1; SMN2HPGD
SCHEMBL18976466 0.79 HRAS (0.41) RAB9ANPC1ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640507-B2 PBD antibacterial agents KING'S COLLEGE LONDON (GB) 2020-05-05 — — US disclosed
US-20180354958-A1 PBD ANTIBACTERIAL AGENTS Secretary of State for Health and Social Care (GB) 2018-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10640507-B2 PBD antibacterial agents OPRD1, XDH, SBDS RAB9A 3045/4885NPC1 2404/4885ALDH1A1 2651/4885
US-20180354958-A1 PBD ANTIBACTERIAL AGENTS OPRD1, XDH, SBDS RAB9A 3045/4885NPC1 2404/4885ALDH1A1 2651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback